Poster Presentation 2025 National Cancer Survivorship Conference

Return-to-work of Cancer Survivors: A Scoping Review (#79)

Xi Wen (Carys) Chan 1 , June Khaw 2 , Monique Esterhuizen 2 , Wajeeha Khalil 1
  1. Centre for Work, Organisation and Wellbeing (WOW), Griffith University, Nathan, QLD, Australia
  2. Hannover Life Re of Australasia Ltd, Sydney, NSW, Australia

This joint research collaboration between Griffith University and Hannover Life Re of Australasia examines the return-to-work (RTW) experiences of cancer survivors, drawing upon a comprehensive review of 320 empirical research articles published between 2013 and 2023. Analysis reveals RTW success rates varying from 8.7% to 100%, with an average of 66.91%, highlighting the complexity of reintegration into the workforce. The scoping review identifies various barriers and facilitators influencing survivors' ability to reenter the workforce. Key barriers include cancer-related symptoms, treatment side effects, psychological distress, financial concerns, and workplace challenges. Physical limitations, fatigue, and cognitive impairment were particularly prevalent, affecting both job performance and retention. The research also revealed significant disparities in RTW outcomes based on cancer type, with breast cancer survivors being the most extensively studied population. Mental health emerged as a crucial factor, with 50 studies reporting depression or anxiety as significant barriers to successful workforce reintegration. Facilitators encompass physical and psychological interventions, workplace accommodations, social support, and a positive mindset among survivors. The findings of this review highlight the multifaceted support cancer survivors require as they reenter the workforce. While workplace interventions and accommodations are crucial, addressing the financial impact of cancer is equally essential. Life insurance can serve as a vital financial safeguard, offering much-needed support for cancer survivors and their families during and after treatment. By understanding the challenges faced when diagnosed with, treated for, or overcoming cancer, life insurers can explore new ways of providing support to policyholders through personalised cancer products and recovery programs. Ongoing research and collaboration among stakeholders are key to developing innovative life insurance solutions that empower cancer survivors with comprehensive financial security, ultimately promoting their wellbeing and resilience throughout their journey.